Minghong Sports

Hunan Erkang Pharmaceutical Co., Ltd. (stock code: 300267) was established in October 2003 and listed on the Shenzhen Stock Exchange on September 27, 2011. The company is located in the scenic *Liuyang Economic and Technological Development Zone. Since its establishment, the company has been engaged in the research and development, production and sales of pharmaceutical products, mainly including pharmaceutical excipients, active pharmaceutical ingredients and new antibiotics.
The company is one of the domestic professional pharmaceutical excipient manufacturers with the *most complete varieties and *largest scale, and is one of the few domestic enterprises with registration approval documents for both the API and finished drug of sulbenicillin sodium, a new type of penicillin antibiotic.
Erkang Pharmaceutical is the formulator and promoter of domestic pharmaceutical excipient industry standards. Adhering to the business philosophy of "Professionalism achieves the future, quality creates brilliance", it achieves professional production, serialized varieties, scientific application and quality service. At the same time, with the mission of "Everything for the safety of medicines", the company regards the quality and safety of products such as pharmaceutical excipients as the life of the enterprise. Leveraging its advantages in the field of pharmaceutical excipients, the company strives to improve the quality level of pharmaceutical excipients, promote the construction of pharmaceutical excipient standards system, actively develop pharmaceutical excipient products for various preparations, achieve variety scale and quality standardization, and strive to build the company into the * of China's pharmaceutical excipient industry.

Honors obtained since the company's listing:
In August 2011, won the "Top Ten Pharmaceutical API and Excipient Brands"
In January 2012, won Forbes: 2012 China's *Most Potential ChiNext Listed Companies (7th place)
In July 2012, won the 2011 Golden Bull *Best Entrepreneurial Growth Company (2nd place)
In August 2013, won the "China ChiNext Listed Companies Top 20 by Value" (8th place) and "China ChiNext Listed Companies Top Ten Management Teams" (10th place); won the 2012 (6th) Pharmaceutical Industry "Top Ten National Brands" title
In February 2014, won two honorary titles: "2013 Changsha Top 30 Industrial Enterprises" and "2013 Enterprises with Profits and Taxes Exceeding 100 Million Yuan"